0029

COM:DOUBLE-MEDICAL

Double Medical

  • Stock

Last Close

34.58

08/11 05:15

Market Cap

10.61B

Beta: -

Volume Today

1.15M

Avg: -

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe NowHelp
Dec '13
Dec '14
Dec '15
Dec '16
Dec '17
Dec '18
Dec '19
Dec '20
Dec '21
Dec '22
Dec '23
average inventory
73.20M
-
103.96M
42.02%
138.47M
33.20%
179.36M
29.53%
233.28M
30.06%
360.79M
54.66%
499.57M
38.46%
606.09M
21.32%
828.75M
36.74%
1.09B
31.56%
average payables
16.43M
-
21.54M
31.14%
21.21M
1.54%
26.75M
26.13%
35.93M
34.28%
125.50M
249.32%
195.46M
55.75%
238.06M
21.79%
320.83M
34.77%
313.50M
2.28%
average receivables
83.04M
-
101.66M
22.43%
71.61M
29.56%
70.26M
1.88%
85.39M
21.52%
178.56M
109.11%
294.50M
64.93%
413.61M
40.44%
436.28M
5.48%
324.39M
25.65%
book value per share
0.70
-
0.85
21.02%
1.37
61.89%
1.60
16.14%
3.32
108.12%
3.61
8.52%
4.29
19.02%
5.25
22.24%
6.27
19.52%
7.16
14.17%
7.39
3.22%
capex per share
-0.09
-
-0.25
174.05%
-0.24
5.21%
-0.09
61.28%
-0.10
7.65%
-0.26
159.24%
-0.80
207.41%
-0.34
57.03%
-0.59
71.59%
-0.68
15.93%
-0.74
8.58%
capex to depreciation
-6.26
-
-4.34
30.63%
-1.48
65.98%
-1.53
3.31%
-3.61
136.38%
-8.02
122.30%
-2.72
66.05%
-3.32
21.79%
-2.98
10.05%
-1.57
47.31%
capex to operating cash flow
-0.28
-
-0.53
93.15%
-0.62
16.04%
-0.16
74.03%
-0.12
25.78%
-0.31
158.36%
-0.74
138.38%
-0.25
66.47%
-0.35
41.53%
-2.22
535.55%
-3.56
60.56%
capex to revenue
-0.15
-
-0.27
85.81%
-0.20
27.69%
-0.07
63.10%
-0.06
13.85%
-0.13
115.52%
-0.25
89.75%
-0.09
65.97%
-0.12
36.42%
-0.20
68.62%
-0.20
1.26%
cash per share
0.12
-
0.31
167.34%
0.11
63.66%
0.17
54.39%
1.39
699.39%
2.08
49.52%
2.30
10.58%
2.66
15.60%
2.94
10.68%
3.22
9.50%
4.01
24.45%
days of inventory on hand
511.24
-
538.00
5.23%
590.95
9.84%
684.92
15.90%
733.24
7.05%
637.44
13.07%
922.23
44.68%
882.29
4.33%
786.37
10.87%
1.08K
37.24%
825.21
23.54%
days payables outstanding
92.47
-
136.46
47.56%
102.49
24.89%
94.26
8.04%
115.94
23.00%
96.16
17.06%
425.87
342.87%
292.73
31.26%
347.68
18.77%
377.51
8.58%
194.77
48.41%
days sales outstanding
70.25
-
155.17
120.88%
71.03
54.23%
52.84
25.61%
45.20
14.46%
45.94
1.64%
75.45
64.24%
75.70
0.34%
91.16
20.42%
95.31
4.55%
65.93
30.83%
debt to assets
0.03
-
0.01
-
0.02
215.66%
0.13
629.28%
debt to equity
0.07
-
0.01
-
0.02
207.98%
0.19
742.91%
dividend yield
0.00
-
0.00
14,167.55%
0.01
1,461.59%
0.01
29.01%
0.01
29.34%
0.01
93.26%
0.01
35.57%
0.01
2.23%
0.02
84.27%
0.01
9.46%
earnings yield
0.02
-
0.03
43.88%
0.04
35.33%
0.04
3.39%
0.02
41.77%
0.03
45.79%
0.02
37.54%
0.02
3.77%
0.03
60.28%
0.01
80.80%
0.00
45.72%
enterprise value
5.07B
-
5.02B
0.87%
5.07B
0.90%
5.68B
12.10%
12.78B
124.94%
10.63B
16.81%
22.22B
109.06%
28.26B
27.17%
19.60B
30.65%
13.34B
31.94%
16.18B
21.27%
enterprise value over ebitda
47.20
-
26.91
42.99%
21.34
20.71%
21.36
0.13%
33.48
56.70%
22.30
33.39%
36.59
64.10%
36.64
0.13%
21.83
40.42%
52.11
138.71%
80.01
53.55%
ev to operating cash flow
47.57
-
33.24
30.13%
41.05
23.52%
27.43
33.19%
41.39
50.93%
31.74
23.31%
51.22
61.36%
50.85
0.72%
29.11
42.75%
103.86
256.74%
188.57
81.56%
ev to sales
25.00
-
16.80
32.79%
12.93
23.03%
12.28
5.06%
21.51
75.20%
13.76
36.03%
17.68
28.45%
17.81
0.76%
9.83
44.82%
9.30
5.35%
10.65
14.51%
free cash flow per share
0.24
-
0.22
8.65%
0.15
33.34%
0.48
229.18%
0.74
52.22%
0.58
21.22%
0.29
50.73%
1.04
265.50%
1.09
4.75%
-0.37
134.18%
-0.53
42.16%
free cash flow yield
0.02
-
0.01
8.65%
0.01
33.34%
0.03
229.18%
0.02
32.41%
0.02
1.21%
0.00
75.33%
0.01
191.37%
0.02
50.90%
-0.01
150.10%
-0.01
19.19%
graham net net
0.08
-
-0.10
235.31%
0.11
203.51%
0.15
37.09%
1.41
870.51%
2.08
47.31%
2.15
3.43%
2.70
25.54%
2.74
1.56%
3.09
12.86%
2.50
19.12%
graham number
2.19
-
2.89
31.95%
4.27
48.02%
4.68
9.58%
7.73
65.21%
8.69
12.32%
10.58
21.84%
13.35
26.14%
15.39
15.32%
5.95
61.33%
4.87
18.25%
income quality
1.10
-
1.09
0.62%
0.65
40.17%
0.93
42.67%
1.03
10.03%
0.89
13.75%
0.91
2.33%
0.90
0.25%
0.97
7.70%
1.18
20.78%
1.45
23.71%
intangibles to total assets
0.11
-
0.11
4.08%
0.10
8.33%
0.07
26.71%
0.04
47.51%
0.03
25.11%
0.02
29.42%
0.05
156.80%
0.06
22.58%
0.05
16.52%
0.01
72.71%
interest coverage
234.88
-
199.88
14.90%
345.14
72.68%
70.85
79.47%
108.97
53.79%
1.50K
-
47.61
96.82%
1.04
97.81%
interest debt per share
0.00
-
0.06
3,954.99%
0.00
96.70%
0.01
391.67%
0.01
8.60%
0.05
-
0.17
256.99%
1.44
743.00%
inventory turnover
0.71
-
0.68
4.97%
0.62
8.96%
0.53
13.72%
0.50
6.59%
0.57
15.03%
0.40
30.88%
0.41
4.53%
0.46
12.20%
0.34
27.14%
0.44
30.78%
invested capital
0.07
-
0.01
-
0.02
207.98%
0.19
742.91%
market cap
5.10B
-
5.10B
0%
5.10B
0%
5.74B
12.54%
13.29B
131.42%
11.46B
13.79%
22.99B
100.63%
28.83B
25.39%
19.99B
30.64%
14.26B
28.65%
16.81B
17.81%
net current asset value
115.01M
-
66.97M
41.77%
181.02M
170.30%
313.31M
73.08%
958.52M
205.94%
1.12B
17.32%
1.16B
3.37%
1.47B
26.51%
1.60B
9.05%
1.90B
18.19%
1.73B
8.91%
net debt to ebitda
-0.34
-
-0.43
26.36%
-0.15
65.11%
-0.24
55.19%
-1.34
470.77%
-1.74
29.24%
-1.26
27.51%
-0.73
42.03%
-0.44
40.24%
-3.61
727.77%
-3.10
14.00%
net income per share
0.30
-
0.44
43.88%
0.59
35.33%
0.61
3.39%
0.80
31.15%
0.93
16.25%
1.16
24.73%
1.51
30.17%
1.68
11.26%
0.22
86.90%
0.14
35.26%
operating cash flow per share
0.33
-
0.47
41.88%
0.39
18.31%
0.58
49.10%
0.84
45.05%
0.84
0.34%
1.08
28.96%
1.39
28.15%
1.68
21.24%
0.31
81.76%
0.21
32.38%
payables turnover
3.95
-
2.67
32.23%
3.56
33.14%
3.87
8.74%
3.15
18.70%
3.80
20.56%
0.86
77.42%
1.25
45.48%
1.05
15.80%
0.97
7.90%
1.87
93.82%
receivables turnover
5.20
-
2.35
54.73%
5.14
118.47%
6.91
34.43%
8.08
16.90%
7.95
1.61%
4.84
39.11%
4.82
0.33%
4.00
16.96%
3.83
4.35%
5.54
44.56%
research and ddevelopement to revenue
0.08
-
0.09
14.70%
0.09
5.43%
0.09
4.60%
0.08
7.13%
0.08
4.85%
0.08
1.06%
0.08
3.83%
0.18
113.69%
0.18
0.69%
return on tangible assets
0.37
-
0.29
21.47%
0.37
30.13%
0.33
11.82%
0.22
32.76%
0.23
3.74%
0.21
7.61%
0.24
14.19%
0.21
12.14%
0.02
88.38%
0.01
47.89%
revenue per share
0.63
-
0.94
47.49%
1.23
31.09%
1.29
4.93%
1.61
24.95%
1.93
20.29%
3.13
62.01%
3.96
26.26%
4.98
25.78%
3.42
31.25%
3.67
7.22%
roe
0.43
-
0.51
18.89%
0.43
16.40%
0.38
10.98%
0.24
36.99%
0.26
7.12%
0.27
4.80%
0.29
6.49%
0.27
6.91%
0.03
88.53%
0.02
37.27%
roic
0.41
-
0.46
11.93%
0.41
10.45%
0.36
12.53%
0.25
31.71%
0.26
7.04%
0.28
6.24%
0.29
5.48%
0.28
5.42%
0.04
87.27%
0.00
94.79%
sales general and administrative to revenue
0.14
-
0.02
85.96%
0.03
35.70%
0.03
16.24%
0.02
51.50%
0.02
6.91%
0.01
31.54%
0.01
8.14%
0.01
12.05%
0.03
133.47%
shareholders equity per share
0.70
-
0.85
21.02%
1.37
61.89%
1.60
16.14%
3.32
108.12%
3.61
8.52%
4.29
19.02%
5.25
22.24%
6.27
19.52%
7.16
14.17%
7.39
3.22%
stock based compensation to revenue
-0.40
-
tangible asset value
193.29M
-
214.35M
10.89%
385.16M
79.69%
526.96M
36.82%
1.18B
124.81%
1.41B
18.98%
1.71B
21.15%
1.99B
16.83%
2.37B
18.80%
2.89B
22.12%
3.14B
8.57%
tangible book value per share
0.60
-
0.67
10.89%
1.21
79.69%
1.47
21.58%
3.21
118.79%
3.53
10.05%
4.26
20.58%
4.97
16.88%
5.91
18.90%
6.91
16.76%
7.59
9.92%
working capital
121.82M
-
78.61M
35.47%
215.23M
173.79%
345.15M
60.37%
990.52M
186.98%
1.16B
16.62%
1.22B
5.78%
1.53B
25.40%
1.67B
9.20%
2.01B
20.10%
2.00B
0.40%

All numbers in (except ratios and percentages)